Chapter 12: Human Microbiome Analysis by Morgan, Xochitl C. & Huttenhower, Curtis
 
Chapter 12: Human Microbiome Analysis
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Morgan, Xochitl C., and Curtis Huttenhower. 2012. Chapter 12:
human microbiome analysis. PLoS Computational Biology 8(12):
e1002808.
Published Version doi:10.1371/journal.pcbi.1002808
Accessed February 19, 2015 11:56:13 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10941811
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAEducation




1Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America, 2The Broad Institute of MIT and Harvard, Cambridge,
Massachusetts, United States of America
Abstract: Humans are essentially
sterile during gestation, but during
and after birth, every body surface,
including the skin, mouth, and gut,
becomes host to an enormous
variety of microbes, bacterial, ar-
chaeal, fungal, and viral. Under
normal circumstances, these mi-
crobes help us to digest our food
and to maintain our immune sys-
tems, but dysfunction of the hu-
man microbiota has been linked to
conditions ranging from inflamma-
tory bowel disease to antibiotic-
resistant infections. Modern high-
throughput sequencing and bioin-
formatic tools provide a powerful
means of understanding the con-
tribution of the human microbiome
to health and its potential as a
target for therapeutic interven-
tions. This chapter will first discuss
the historical origins of microbiome
studies and methods for determin-
ing the ecological diversity of a
microbial community. Next, it will
introduce shotgun sequencing
technologies such as metage-
nomics and metatranscriptomics,
the computational challenges and
methods associated with these
data, and how they enable micro-
biome analysis. Finally, it will con-
clude with examples of the func-
tional genomics of the human
microbiome and its influences up-
on health and disease.
This article is part of the ‘‘Transla-
tional Bioinformatics’’ collection for
PLOS Computational Biology.
1. Introduction
The question of what it means to be
human is more often encountered in
metaphysics than in bioinformatics, but it
is surprisingly relevant when studying the
human microbiome. We are born consist-
ing only of our own eukaryotic human
cells, but over the first several years of life,
our skin surface, oral cavity, and gut are
colonized by a tremendous diversity of
bacteria, archaea, fungi, and viruses. The
community formed by this complement of
cells is called the human microbiome; it
contains almost ten times as many cells as
are in the rest of our bodies and accounts
for several pounds of body weight and
orders of magnitude more genes than are
contained in the human genome [1,2].
Under normal circumstances, these mi-
crobes are commensal, helping to digest
our food and to maintain our immune
systems. Although the human microbiome
has long been known to influence human
health and disease [1], we have only
recently begun to appreciate the breadth
of its involvement. This is almost entirely
due to the recent ability of high-through-
put sequencing to provide an efficient and
cost-effective tool for investigating the
members of a microbial community and
how they change. Thus, dysfunctions of
the human microbiota are increasingly
being linked to disease ranging from
inflammatory bowel disease to diabetes
to antibiotic-resistant infection, and the
potential of the human microbiome as an
early detection biomarker and target for
therapeutic intervention is a vibrant area
of current research.
2. A Brief History of Microbiome
Studies
Historically, members of a microbial
community were identified in situ by stains
that targeted their physiological character-
istics, such as the Gram stain [3]. These
could distinguish many broad clades of
bacteria but were non-specific at lower
taxonomic levels. Thus, microbiology was
almost entirely culture-dependent; it was
necessary to grow an organism in the lab
in order to study it. Specific microbial
species were detected by plating samples
on specialized media selective for the
growth of that organism, or they were
identified by features such as the morpho-
logical characteristics of colonies, their
growth on different media, and metabolic
production or consumption. This ap-
proach limited the range of organisms
that could be detected to those that would
actively grow in laboratory culture, and it
led the close study of easily-grown, now-
familiar model organisms such as Esche-
richia coli. However, E. coli as a taxonomic
unit accounts for at most 5% of the
microbes occupying the typical human
gut [2]. The vast majority of microbial
species have never been grown in the
laboratory, and options for studying and
quantifying the uncultured were severely
limited until the development of DNA-
based culture-independent methods in the
1980s [4].
Culture-independent techniques, which
analyze the DNA extracted directly from
a sample rather than from individually
cultured microbes, allow us to investigate
several aspects of microbial communities
(Figure 1). These include taxonomic
diversity, such as how many of which
microbes are present in a community,
and functional metagenomics, which at-
tempts to describe which biological tasks
the members of a community can or do
carry out. The earliest DNA-based meth-
ods probed extracted community DNA
for genes of interest by hybridization, or
amplified specifically-targeted genes by
PCR prior to sequencing. These studies
were typically able to describe diversity at
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27a broad level, or detect the presence or
absence of individual biochemical func-
tions, but with few details in either case.
One of the earliest targeted metage-
nomic assays for studying uncultured
communities without prior DNA extrac-
tion was fluorescent in situ hybridization
(FISH), in which fluorescently-labeled,
specific oligonuclotide probes for marker
genes are hybridized to a microbial
community [5]. FISH probes can be
targeted to almost any level of taxonomy
from species to phylum. Although FISH
was initially limited to the 16S rRNA
marker gene and thus to diversity studies,
it has since been expanded to functional
gene probes that can be used to identify
specific enzymes in communities [6].
However, it remains a primarily low-
throughput, imaging-based technology.
To investigate microbial communities
efficiently at scale, almost all current
studies employ high-throughput DNA
sequencing, increasingly in combination
with other genome-scale platforms such as
proteomics or metabolomics. Although
DNA sequencing has existed since the
1970s [7,8], it was historically quite
expensive; sequencing environmental
DNA further required the additional time
and expense of clone library construction.
It was not until the 2005 advent of next-
generation high-throughput sequencing
[9] that it became economically feasible
for most scientists to sequence the DNA of
an entire environmental sample, and
metagenomic studies have since become
increasingly common.
3. Taxonomic Diversity
3.1 The 16S rRNA Marker Gene
Like a metazoan, a microbial commu-
nity consists fundamentally of a collection
of individual cells, each carrying a distinct
complement of genomic DNA. Commu-
nities, however, obviously differ from
multicellular organisms in that their com-
ponent cells may or may not carry
identical genomes, although substantial
subsets of these cells are typically assumed
to be clonal. One can thus assign a
frequency to each distinct genome within
the community describing either the
absolute number of cells in which it is
carried or their relative abundance within
the population. As it is impractical to fully
sequence every genome in every cell (a
statement that should remain safely true
no matter how cheap high-throughput
sequencing becomes), microbial ecology
has defined a number of molecular
markers that (more or less) uniquely tag
distinct genomes. Just as the make, model,
and year of a car identify its components
without the need to meticulously inspect
the entirety of every such car, a marker is a
DNA sequence that identifies the genome
that contains it, without the need to
sequence the entire genome.
Although different markers can be
chosen for analyzing different populations,
several properties are desirable for a good
marker. A marker should be present in
every member of a population, should
differ only and always between individuals
with distinct genomes, and, ideally, should
differ proportionally to the evolutionary
distance between distinct genomes. Sever-
al such markers have been defined,
including ribosomal protein subunits,
elongation factors, and RNA polymerase
subunits [10], but by far the most
ubiquitous (and historically significant
[11]) is the small or 16S ribosomal RNA
subunit gene [12]. This 1.5 Kbp gene is
commonly referred to as the 16S rRNA
(after transcription) or sometimes rDNA; it
satisfies the criteria of a marker by
containing both highly conserved, ubiqui-
tous sequences and regions that vary with
greater or lesser frequency over evolution-
ary time. It is relatively cheap and simple
to sequence only the 16S sequences from a
microbiome [13], thus describing the
population as a set of 16S sequences and
the number of times each was detected.
Sequences assayed in this manner have
been characterized for a wide range of
cultured species and environmental iso-
lates; these are stored and can be auto-
matically matched against several data-
bases including GreenGenes [14], the
Ribosomal Database Project [15], and
Silva [16].
3.2 Binning 16S rRNA Sequences
into OTUs
A bioinformatic challenge that arises
immediately in the analysis of rRNA genes
is the precise definition of a ‘‘unique’’
sequence. Although much of the 16S
rRNA gene is highly conserved, several
of the sequenced regions are variable or
hypervariable, so small numbers of base
pairs can change in a very short period of
evolutionary time [17]. Horizontal trans-
fer, multicopy or ambiguous rDNA mark-
ers, and other confounding factors do,
however, blur the biological meaning of
‘‘species’’ as well as our ability to resolve
them technically [17]. Finally, because
16S regions are typically sequenced using
only a single pass, there is a fair chance
that they will thus contain at least one
sequencing error. This means that requir-
ing tags to be 100% identical will be
extremely conservative and treat essential-
ly clonal genomes as different organisms.
Some degree of sequence divergence is
typically allowed - 95%, 97%, or 99% are
sequence similarity cutoffs often used in
practice [18] - and the resulting cluster of
nearly-identical tags (and thus assumedly
identical genomes) is referred to as an
Operational Taxonomic Unit (OTU) or
sometimes phylotype. OTUs take the
place of ‘‘species’’ in many microbiome
diversity analyses because named species
genomes are often unavailable for partic-
ular marker sequences. The assignment of
sequences to OTUs is referred to as
binning, and it can be performed by A)
unsupervised clustering of similar sequenc-
es [19], B) phylogenetic models incorpo-
rating mutation rates and evolutionary
relationships [20], or C) supervised meth-
ods that directly assign sequences to
taxonomic bins based on labeled training
data [21] (which also applies to whole-
genome shotgun sequences; see below).
The binning process allows a commu-
nity to be analyzed in terms of discrete
bins or OTUs, opening up a range of
computationally tractable representations
for biological analysis. If each OTU is
treated as a distinct category, or each 16S
sequence is binned into a named phylum
or other taxonomic category, a pool of
microbiome sequences can be represented
as a histogram of bin counts [22].
Alternately, this histogram can be binar-
ized into presence/absence calls for each
bin across a collection of related samples.
Because diverse, general OTUs will always
be present in related communities, and
overly-specific OTUs may not appear
outside of their sample of origin, the latter
approach is typically most useful for low-
complexity microbiomes or OTUs at an
What to Learn in This Chapter
N An overview of the analysis of microbial communities
N Understanding the human microbiome from phylogenetic and functional
perspectives
N Methods and tools for calculating taxonomic and phylogenetic diversity
N Metagenomic assembly and pathway analysis
N The impact of the microbiome on its host
PLOS Computational Biology | www.ploscompbiol.org 2 December 2012 | Volume 8 | Issue 12 | e1002808Figure 1. Bioinformatic methods for functional metagenomics. Studies that aim to define the composition and function of uncultured
microbial communities are often referred to collectively as ‘‘metagenomic,’’ although this refers more specifically to particular sequencing-based
assays. First, community DNA is extracted from a sample, typically uncultured, containing multiple microbial members. The bacterial taxa present in
PLOS Computational Biology | www.ploscompbiol.org 3 December 2012 | Volume 8 | Issue 12 | e1002808appropriately tuned level of specificity.
Bioinformaticians studying 16S sequences
must choose whether to analyze a collec-
tion of taxonomically-binned microbiomes
as a set of abundance histograms, or as a
set of binary presence/absence vectors.
However, either representation can be
used as input to decomposition methods
such as Principle Components Analysis or
Canonical Correlation Analysis [23] to
determine which OTUs represent the
most significant sources of population
variance and/or correlate with community
metadata such as temperature, pH, or
clinical features [24,25].
3.3 Measuring Population Diversity
An important concept when dealing
with OTUs or other taxonomic bins is that
of population diversity, the number of
distinct bins in a sample or in the
originating population. This is of critical
importance in human health, since a
number of disease conditions have been
shown to correlate with decreased micro-
biome diversity, presumably as one or a
few microbes overgrow during immune or
nutrient imbalance in a process not unlike
an algal bloom [26]. Intriguingly, recent
results have also shown that essentially no
bacterial clades are widely and consistently
shared among the human microbiome [2].
Many organisms are abundant in some
individuals, and many organisms are
prevalent among most individuals, but
none are universal. Although they can
vary over time and share some similarity
with some individuals, our intestinal con-
tents appear to be highly personalized
when considered in terms of microbial
presence, absence, and abundance.
Two mathematically well-defined ques-
tions arise when quantifying population
diversity (Figure 2): given that x bins have
been observed in a sample of size y from a
population of size z, how many bins are
expected to exist in the population; or,
given that x bins exist in a population of
size z, how big must the sample size y be to
observe all of them at least once? In other
words, ‘‘If I’ve sequenced some amount of
diversity, how much more exists in my
microbiome?’’ and, ‘‘How much do I need
to sequence to completely characterize my
microbiome?’’ The latter is known as the
Coupon Collector’s Problem, as identical
questions can be asked if a cereal manu-
facturer has randomly hidden one of
several different possible prize coupons in
each box of cereal [27]. Within a com-
munity, several estimators including the
Chao1 [28], Abundance-based Coverage
Estimator (ACE) [29], and Jackknife [30]
measures exist for calculating alpha diver-
sity, the number (richness) and distribution
(evenness) of taxa expected within a single
population. These give rise to figures
known as collector’s or rarefaction curves,
since increasing numbers of sequenced
taxa allow increasingly precise estimates of
total population diversity [31]. Addition-
ally, when comparing multiple popula-
the community are most frequently defined by amplifying the 16S rRNA gene and sequencing it. Highly similar sequences are grouped into
Operational Taxonomic Units (OTUs), which can be compared to 16S databases such as Silva [16], Green Genes [14], and RDP [15] to identify them as
precisely as possible. The community can be described in terms of which OTUs are present, their relative abundance, and/or their phylogenetic
relationships. An alternate method of identifying community taxa is to directly metagenomically sequence community DNA and compare it to
reference genomes or gene catalogs. This is more expensive but provides improved taxonomic resolution and allows observation of single nucleotide
polymorphisms (SNPs) and other variant sequences. The functional capabilities of the community can also be determined by comparing the
sequences to functional databases (e.g. KEGG [170] or SEED [171]). This allows the community to be described as relative abundances of its genes and
pathways. Figure adapted from [172].
doi:10.1371/journal.pcbi.1002808.g001
Figure 2. Ecological representations of microbial communities: collector’s curves, alpha, and beta diversity. These examples describe
the A) sequence counts and B) relative abundances of six taxa (A, B, C, D, E, and F) detected in three samples. C) A collector’s curve, typically
generated using a richness estimator such as Chao1 [28] or ACE [29], approximates the relationship between the number of sequences drawn from
each sample and the number of taxa expected to be present based on detected abundances. D) Alpha diversity captures both the organismal
richness of a sample and the evenness of the organisms’ abundance distribution. Here, alpha diversity is defined by the Shannon index [32],
H’~{
PS
i~1 (pi ln(pi)), where pi is the relative abundance of taxon i, although many other alpha diversity indices may be employed. E) Beta diversity
represents the similarity (or difference) in organismal composition between samples. In this example, it can be simplistically defined by the equation
b~(ni{c)z(n2{c), where n1 and n2 are the number of taxa in samples 1 and 2, respectively, and c is the number of shared taxa, but again many
metrics such as Bray-Curtis [34] or UniFrac [24] are commonly employed.
doi:10.1371/journal.pcbi.1002808.g002
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absolute or relative overlap describe how
many taxa are shared between them
(Figure 2). An alpha diversity measure
thus acts like a summary statistic of a single
population, while a beta diversity measure
acts like a similarity score between popu-
lations, allowing analysis by sample clus-
tering or, again, by dimensionality reduc-
tions such as PCA [20]. Alpha diversity is
often quantified by the Shannon Index
[32], H’~{
PS
i~1 (pi ln(pi)), or the




pi is the fraction of total species comprised
by species i. Beta diversity can be mea-
sured by simple taxa overlap or quantified




, where Si and Sj are
the number of species in populations i and
j, and Cij is the total number of species at
the location with the fewest species. Like
similarity measures in expression array
analysis, many alpha- and beta-diversity
measures have been developed that each
reveal slightly different aspects of commu-
nity ecology.
Alternatively, the diversity within or
among communities can be analyzed in
terms of its phylogenetic distribution
rather than by isolating discrete bins. This
method of quantifying community diver-
sity describes it in terms of the total
breadth or depth of the phylogenetic
branches spanned by a microbiome (or
shared among two or more). For example,
consider a collection of n highly-related
16S sequences. These might be treated
either as one OTU or as n distinct taxa,
depending on how finely they are binned,
but a phylogenetic analysis will consider
them to span a small evolutionary distance
no matter how large n becomes. Con-
versely, two highly-divergent binned
OTUs are typically no different than two
similar OTUs, but a phylogenetic method
would score them as spanning a large
evolutionary distance. OTU-based and
phylogenetic methods tend to be comple-
mentary, in that each will reveal different
aspects of community structure. OTUs are
highly sensitive to the specific means by
which taxa are binned, for example,
whereas phylogenetic measures are sensi-
tive to the method of tree construction.
Like the OTU-based diversity estimators
discussed above, several standard metrics
such as UniFrac [20] exist for quantifying
phylogenetic diversity, and these can be
treated as single-sample descriptors or as
multiple-sample similarity measures.
It is critically important in any micro-
biome richness analysis to account for the
contribution that technical noise will make
to apparent diversity. As a simple example,
consider that a single base pair error in a
100 bp sequence read will create a new
OTU at the 99% similarity threshold.
Apparent diversitycanthus be dramatically
modified by the choice of marker gene, the
region within it that is sequenced, the
biochemical marker extraction and ampli-
fication processes, and the read length and
noise characteristics of the sequencing
platform. Accounting for such errors com-
putationally continues to be a fruitful area
of research, particularly as 454-based
technologies have transitioned to the Illu-
mina platform, as current solutions can
discard all but the highest-quality sequence
regions [18]. A major confound in many
early molecular richness analyses was the
abundance of chimeric sequences, or reads
in which two unique marker sequences
(typically 16S regions) adhere during the
amplification process, creating an appar-
ently novel taxon. Although sequence
chimeras can now be reliably removed
computationally [13,19,35], this filtering
process is still an essential early step in any
microbiome analysis.
A final consideration in the computa-
tional analysis of community structure
assays is the use of microarray-based
methods for 16S (and other marker)
quantification within a microbiome. Just
as high-throughput RNA sequencing par-
allels gene expression microarrays, 16S
rDNA sequencing parallels phylochips,
microarrays constructed with probes com-
plementary to a variety of 16S and other
marker sequences [36]. The design and
analysis of such arrays can be challenging,
as 16S sequences (or any good genomic
markers) will be highly similar, and the
potential for extensive cross-hybridization
must be taken into account both when
determining what sequences to place on a
chip and how to quantify their abundance
after hybridization [37]. The continued
usefulness of such arrays will be dictated
by future trends in high-throughput se-
quencing costs and barcoding, but at
present phylochips are beginning to be
constructed to capture functional sequenc-
es in combination with measures of taxon
abundances in high throughput, and they
represent an interesting option for popu-
lation-level microbiome assays.
4. Shotgun Sequencing and
Metagenomics
While measures of community diversity
have dominated historical analyses, mod-
ern high-throughput methods are being
developed for a host of other ‘‘meta’’
assays from uncultured microbes. The
term metagenomics is used with some
frequency to describe the entire body of
high-throughput studies now possible with
microbial communities, although it also
refers more specifically to whole-metagen-
ome shotgun (WMS) sequencing of geno-
mic DNA fragments from a community’s
metagenome [38,39]. Metatranscrip-
tomics, a close relative, implies shotgun
sequencing of reverse-transcribed RNA
transcripts [40,41], metaproteomics
[42,43] the quantification of protein or
peptide levels, and metametabolomics (or
less awkwardly community metabolomics)
[44,45] the investigation of small-molecule
metabolites. Of these assays, the latter
three in particular are still in their infancy,
but are carried out using roughly the same
technologies as their culture-based coun-
terparts, and the resulting data can
typically be analyzed using comparable
computational methods.
As of this writing, no complete meta-
metabolomic studies from uncultured mi-
crobiomes have yet been published, al-
though their potential usefulness in
understanding e.g. the human gut micro-
biome and its role in energy harvest,
obesity, and metabolic disorders is clear
[44]. Metaproteomic and metatranscrip-
tomic studies have primarily focused on
environmental samples [46,47,48], but
human stool metatranscriptomics [41,49]
and medium-throughput human gut me-
taproteomics [42,43] have also been
successfully executed and analyzed using
bioinformatics similar to those for meta-
genomes (see below) [42]. Quantification
of the human stool metatranscriptome and
metaproteome in tandem with host bio-
molecular activities should yield fascinat-
ing insights into our relationship with our
microbial majority.
DNA extraction and WMS sequencing
from uncultured samples developed, like
many sequencing technologies, concur-
rently with the Human Genome Project
[2,50,51,52], and as with other communi-
ty genomic assays, the earliest applications
were to environmental microbes due to
the ease of isolation and extraction
[53,54]. WMS techniques are in some
ways much the same now as they were
then, modulo the need for complex Sanger
clone library construction: isolate micro-
bial cells of a target size range (e.g. viral,
bacterial, or eukaryotic), lyse the cells
(taking care not to lose DNA to native
DNAses), isolate DNA, fragment it to a
target length, and sequence the resulting
fragments [55,56]. Since this procedure
can be performed on essentially any
heterogeneous population, does not suffer
from the single-copy and evolutionary
PLOS Computational Biology | www.ploscompbiol.org 5 December 2012 | Volume 8 | Issue 12 | e1002808assumptions of marker genes, and does not
require (although can include) amplifica-
tion, it can to some degree produce a less
biased community profile than does 16S
sequencing [57].
4.1 Metagenome Data Analysis
Unlike whole-genome shotgun (WGS)
sequencing of individual organisms, in
which the end product is typically a single
fully assembled genome, metagenomes
tend not to have a single ‘‘finish line’’
and have been successfully analyzed using
a range of assembly techniques. The
simplest is no assembly at all - the short
reads produced as primary data can, after
cleaning to reduce sequencing error [18],
be treated as taxonomic markers or as
gene fragments and analyzed directly.
Since microbial genomes typically contain
few intergenic sequences, most fragments
will contain pieces of one or more genes;
these can be used to quantify enzymatic or
pathway abundances directly as described
below [1,58,59,60]. Alternatively, meta-
genome-specific assembly algorithms have
been proposed that reconstruct only the
open reading frames from a population (its
ORFeome), recruiting highly sequence-
similar fragments on an as-needed basis to
complete single gene sequences and avoid-
ing assembly of larger contigs [61,62]. The
most challenging option is to attempt full
assemblies for complete genomes present
in the community, which is rarely possible
save in very simple communities or with
extreme sequencing depth [53,54]. When
successful, this has the obvious benefit of
establishing synteny, structural variation,
and opening up the range of tools
developed for whole-genome analysis
[63], and guided assemblies using read
mapping (rather than de novo assembly) can
be used when appropriate reference ge-
nomes are available. However, care must
be taken in interpreting any such assem-
blies, since horizontal transfer and com-
munity complexity prevent unambiguous
assemblies in essentially all realistic cases
[64]. A more feasible middle ground is
emerging around maximal assemblies that
capture the largest unambiguous contigs in
a community [65], allowing e.g. local
operon structure to be studied without
introducing artificial homogeneity into the
data. In any of these cases - direct analysis
of reads, ORF assembly, maximal unam-
biguous scaffolds, or whole genomes -
subsequent analyses typically focus on the
functional aspects of the resulting genes
and pathways as detailed below.
A key bioinformatic tradeoff in analyz-
ing metagenomic WMS sequences, re-
gardless of their degree of assembly, is
whether they should be analyzed by
homology, de novo, or a combination
thereof. An illustrative example is the task
of determining which parts of each
sequence read (or ORF/contig/etc.) en-
code one or more genes, i.e. gene finding
or calling. By homology, each sequence
can be BLASTed [66] against a large
database of reference genomes, which will
retrieve any similar known reading frames;
the boundaries of these regions of similar-
ity thus become the start and stop of the
metagenomic open reading frames. This
method is robust to sequencing and
assembly errors, but it is sensitive to the
contents of the reference database. Con-
versely, de novo methods have been devel-
oped to directly bin [67,68,69] and call
genes within [61,62] metagenomic se-
quences using DNA features alone (GC
content, codon usage, etc.). As with
genome analysis for newly sequenced
single organisms, most de novo methods
rely on interpolated [70] or profile [71]
Hidden Markov Models (HMMs) or on
other machine learners that perform
classification based on encoded sequence
features [72,73]. This is a far more
challenging task, making it sensitive to
errors in the computational prediction
process, but it enables a greater range of
discovery and community characterization
efforts by relying less on prior knowledge.
Hybrid methods for e.g. taxonomic bin-
ning [69] have recently been developed
that consume both sequence similarity and
de novo sequence features as input, and for
some tasks such systems might represent a
sweet spot between computational com-
plexity, availability of prior knowledge,
and biological accuracy. This tradeoff
between knowledge transfer by homology
and de novo prediction from sequence is
even more pronounced when characteriz-
ing predicted genes, as discussed below.
5. Computational Functional
Metagenomics
Essentially any analysis of a microbial
community is ‘‘functional’’ in the sense
that it aims to determine the overall
phenotypic consequences of the commu-
nity’s composition and biomolecular ac-
tivity. For example, the Human Micro-
biome Project began to investigate what
typical human microbial community
members are doing [60], how they are
affecting their human hosts [2], what
impact they have on health or disease,
and these help to suggest how pro- or
antibiotics can be used to change commu-
nity behavior for the better [74]. The
approaches referred to as computational
functional metagenomics, however, typi-
cally focus on the function (either bio-
chemically or phenotypically) of individual
genes and gene products within a com-
munity and fall into one of two categories.
Top-down approaches screen a metagen-
ome for a functional class of interest, e.g. a
particular enzyme family, transporter or
chelator, pathway, or biological activity,
essentially asking the question, ‘‘Does this
community carry out this function and, if
so, in what way?’’ Bottom-up approaches
attempt to reconstruct profiles, either
descriptive or predictive, of overall func-
tionality within a community, typically
relying on pathway and/or metabolic
reconstructions and asking the question,
‘‘What functions are carried out by this
community?’’
Either approach relies, first, on catalog-
ing some or all of the gene products
present in a community and assigning
them molecular functions and/or biolog-
ical roles in the typical sense of protein
function predictions [53,54,59]. As with so
many bioinformatic methods, the simplest
techniques rely on BLAST [66]: a top-
down investigation can BLAST represen-
tatives of gene families of interest into the
community metagenome to determine
their presence and abundance [63], and
a bottom-up approach can BLAST reads
or contigs from a metagenome into a large
annotated reference database such as nr to
perform knowledge transfer by homology
[75,76,77]. Top-down approaches dove-
tail well with experimental screens for
individual gene product function [6], and
bottom-up approaches are more descrip-
tive of the community as a whole [78].
As each metagenomic sample can
contain millions of reads and databases
such as nr in turn contain millions of
sequences, computational efficiency is a
critical consideration in either approach.
On one hand, stricter nucleotide searches
or direct read mapping to reference
genomes [79,80] improve runtime and
specificity at the cost of sensitivity; on the
other, more flexible characterizations of
sequence function such as HMMs [72,73]
tend to simultaneously increase coverage,
accuracy, and computational expense.
Any of these sequence annotation methods
can be run directly on short reads, on
ORF assemblies, or on assembled contigs,
and statistical methods have been pro-
posed to more accurately estimate the
frequencies of functions in the underlying
community when they are under-sampled
(requiring the estimation of unobserved
values [81]) or over-sampled (correcting
for loci with greater than 16 coverage
[82]). In any of these cases, the end result
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for each metagenomic sample quantifying
the frequency of gene products in the
community; the profiles for several related
communities can be assembled into a
frequency matrix resembling a microarray
dataset. Gene products (rows) in such a
profile can be identified by functional
descriptors such as Gene Ontology [83]
or KEGG [84] terms, protein families
such as Pfams [73] or TIGRfams [72],
enzymatic [85], transport [86], or other
structural classes [87], or most often as
orthologous families such as Homolo-
Genes [88], COGs [89], NOGs [90], or
KOs [84].
A logical next step, given such an
abundance profile of orthologous families,
is to assemble them into profiles of
community metabolic and functional
pathways. This requires an appropriate
catalog of reference pathways such as
KEGG [84], MetaCyc [91], or GO [83],
although it should be noted that none of
these is currently optimized for modeling
communities rather than single organisms
in monoculture [90]. The pathway infer-
ence process is similar to that performed
when annotating an individual newly
sequenced genome [92] and consists of
three main steps: A) assigning each
ortholog to one or more pathways, B)
gap filling or interpolation of missing
annotations, and C) determining the
presence and/or abundance of each
pathway. The first ortholog assignment
step is necessary since many gene families
participate in multiple pathways; phospho-
enolpyruvate carboxykinase, for example,
is used in the TCA cycle, glycolysis, and in
various intercellular signaling mechanisms
[93]. The abundance mass for each
enzyme is distributed across its functions
in one or more possible pathways; meth-
ods for doing this range from the simple
assumption that it is equally active in all
reference pathways (as currently done by
KAAS [94] or MG-RAST [76]) to the
elimination of unlikely pathways and the
redistribution of associated mass in a
maximum parsimony fashion [95]. Sec-
ond, once all observed orthologs have
been assigned to pathways (when possible),
gaps or holes in the reference pathways
can be filled, using the assumption that the
enzymes necessary to operate a nearly
complete pathway should be present
somewhere in the community. Essentially
three methods have been successfully
employed for gap filling: searching for
alternative pathway fragments to explain
the discrepancy [96,97], purely mathemat-
ical smoothing to replace the missing
enzymes’ abundances with numerically
plausible values [81], and targeted search-
es of the metagenome of interest for more
distant homologues with which to fill the
hole [98]. Since we are currently able to
infer function for only a fraction of the
genes in any given complete genome, let
alone metagenome, any of these ap-
proaches should be deemed hypothetical
at best; nevertheless, like any missing value
imputation process, they can provide
numerically stable guesses that are sub-
stantially better than random [99]. Finally,
as described above for taxa, the resulting
data can be used to summarize each
reference pathway either qualitatively (i.e.
with what likelihood is it present in the
community?) or quantitatively (how abun-
dant is it in the community?), and in its
simplest form condenses the abundance
matrix of orthologous families into an
abundance (or presence/absence) matrix
of pathways. Either the ortholog or
pathway matrices can then be tested for
differentially abundant features represent-
ing diagnostic biomarkers with potential
explanatory power for the phenotype of
interest, using statistical methods devel-
oped for identical tests in expression
biomarker discovery [100] and genome-
wide association studies [101].
However, our prior knowledge of (pri-
marily) metabolic pathways can be lever-
aged to produce richer inferences from
such pathway abundance information.
Given sufficient information about the
pathways in a community, it is relatively
straightforward to predict what metabolic
compounds have the potential to be
produced. However, it is much more
difficult to infer what metabolite pools
and fluxes in the community will actually
be under a specific set of environmental
conditions [102,103]. Multi-organism flux
balance analysis (FBA) is an emerging tool
to enable such analyses [104], but given
the extreme difficulty of constructing
accurate models for even single organisms
[105] or of determining model parameters
in a multi-organism community [53], no
successful reconstructions have yet been
performed for complex microbiomes. The
area holds tremendous promise, however,
first with respect to metabolic engineering
- it is not yet clear what successes might be
achieved with respect to biofuel produc-
tion or bioremediation using synthetically
manipulated communities in place of
individual organisms [106,107]. Second,
in addition to metabolite profiling, multi-
organism growth prediction allows the
determination of mutualisms, parasitisms,
and commensalisms among taxa in the
community [108] [109,110], opening the
door to basic biological discoveries regard-
ing community dynamics [25,111,112]
and to therapeutic probiotic treatments
for dysbioses in the human microbiome
[113,114].
6. Host Interactions and
Interventions
A final but critical aspect of translation-
al metagenomics lies in understanding not
only a microbial community but also its
environment - that is, its interaction with a
human host. Our microbiota would be of
interest to basic research alone if they were
not heavily influenced by host immunity
and, in turn, a major influence on host
health and disease. The skin of humans
hosts relatively few taxa (e.g. Propionibacte-
rium [115]), the nasal cavity somewhat
more (e.g. Corynebacterium [116]), the oral
cavity (dominated by Streptococcus) several
hundred taxa (with remarkable diversity
even among saliva, tongue, teeth, and
other substrates [117,118]) and the gut
over 500 taxa with densities over 10
11
cells/g [2,119]. Almost none of these
communities are yet well-understood, al-
though anecdotes abound. The skin mi-
crobiome is thought to be a key factor in
antibiotic resistant Staphylococcus aureus in-
fections [120,121]; nasal communities
have interacted with the pneumococcus
population to influence its epidemiological
carriage patterns subsequent to vaccina-
tion programs [122]; and extreme dysbio-
sis in cystic fibrosis can be a precursor to
pathogenic infection [123].
The gut, however, is currently the best-
studied human microbiome [119,124,125].
It is a dynamic community changing over
the course of days [126,127], over the
longer time scales of infant development
[112,128,129,130] and aging [131,132], in
response to natural perturbations such as
diet [59,133,134,135] and illness
[114,136], and modified in as-yet-unknown
ways by the modern prevalence of travel,
chemical additives, and antibiotics [126].
Indeed, the human gut microbiome has
provendifficultto studyexactly because itis
so intimately related to the physiology of its
host; inasmuch as no two people share
identical microbiota, most microbiomes are
strikingly divergent between distinct host
species, rendering results from model
organisms difficult to interpret [137,138].
Nevertheless, studies in wild type verte-
brates such as mice[139,140]and zebrafish
[141,142] have found a number of similar-
ities in their microbiotic function and host
interactions. In particular, germ-free or-
ganisms have yielded insights into the
microbiota’s role in maturation of the host
immune system and, surprisingly, even
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[143,144]. Similarly, gnotobiotic systems in
which anorganism’snaturalmicrobiotaare
replaced with their human analog are a
current growth area for closer study of the
phenotypic consequences of controlled
microbiotic perturbations [145].
One of the highest-profile demonstra-
tions of this technique and of the micro-
biota’s influence on human health has
been in an ongoing study of the micro-
biome in obesity [146]. Early studies in
wild-type mice [139] demonstrated gross
taxonomic shifts in the composition and
diversity of the microbiomes of obese
individuals; follow-ups in gnotobiotic mice
confirmed that this phenotype was trans-
missible via the microbiome [147]. These
initial studies were taxonomically focused
and found that, while high-level phyla
were robustly perturbed in obesity (which
incurs a reduction in Bacteroidetes and
concomitant increase in Firmicutes [139]),
few if any specific taxa seemed to be
similarly correlated [138,140]. Subsequent
functional metagenomics, first in mouse
[148] and later a small human cohort [59],
established that the functional consistency
of these shifts operates more consistently,
enriching the microbiome’s capacity for
energy harvest and disregulating fat stor-
age and signaling within the host. While
these observations represent major de-
scriptive triumphs, further computational
and experimental work must yet be
performed to establish the underlying
biomolecular mechanisms and whether
they are correlative, causative, or may be
targeted by interventions to actively treat
obesity [59].
A similarly complex community for
which we have a greater understanding of
the functional mechanisms at play is the
formation of biofilms in the oral cavity
preceding caries (cavities) or periodontitis
[149]. While we are still investigating the
microbiota of the saliva [150] and of the
oral soft tissues [151], colonization of the
tooth enamel is somewhat better under-
stood due to the removal of significant
interaction with host tissue. Even more
strikingly, this biofilm, or physically struc-
tured consortium of multiple microbial
taxa, must reestablish itself from almost
nothing each time we brush our teeth - a
process that can be achieved within hours
[152]. Streptococci in particular possess a
number of surface adhesins and receptors
that enable them to behave as early
colonizers on bare tooth surface and to
bind together a variety of subsequent
microbes [153]. These fairly minimal
bacteria are metabolically supported by
Veillonella and Actinomyces species, and their
aggregation leads to local nutritive and
structural environments favorable to e.g.
Fusobacterium and Porphyromonas [154]. Each
of these steps is mediated by a combination
of cell surface recognition molecules, extra-
cellular physical interactions, metabolic
codependencies, and explicit intercellular
signaling, providing an excellent example
of the complexity with which structured
microbiomes can evolve. Indeed, the evol-
vability of such systems, both as a whole
[155] and at the molecular level [156], is
yet another aspect of the work remaining to
computationally characterize microbiotic
biomolecular and community function.
Finally, the microbiota clearly represent
a key component of future personalized
medicine. First, the number and diversity
of phenotypes linked to the composition of
the microbiota is immense: obesity, diabe-
tes, allergies, autism, inflammatory bowel
disease, fibromyalgia, cardiac function,
various cancers, and depression have all
been reported to correlate with micro-
biome function [157]. Even without caus-
ative or modulatory roles, there is tremen-
dous potential in the ability to use the
taxonomic or metagenomic composition
of a subject’s gut or oral flora (both easily
sampled) as a diagnostic or prognostic
biomarker for any or all of these condi-
tions. Commercial personal genomics
services such as 23andMe (Mountain
View, CA) promise to decode your disease
risk based on somatic DNA from a saliva
sample; bioinformatic techniques have yet
to be developed that will allow us to do the
same using microbial DNA.
Second, the microbiota are amazingly
plastic; they change metagenomically
within hours and metatranscriptomically
within minutes in response to perturba-
tions ranging from broad-spectrum antibi-
otics to your breakfast bacon and eggs
[41,126,127]. For any phenotype to which
they are causally linked, this opens the
possibility of pharmaceutical, prebiotic
(nutrients promoting the growth of bene-
ficial microbes [113,119]), or probiotic
treatments. Indeed, Nobel Prize winner
Ilya Mechnikov famously named Lactoba-
cillus bulgaricus, a primary yogurt-produc-
ing bacterium, for its apparent contribu-
tion to the longevity of yogurt-consuming
Bulgarians [158], and despite a degree of
unfortunate popular hype, the potential
health benefits of a variety of probiotic
organisms are indeed supported by recent
findings [125,159]. Unfortunately, we
currently understand few of the mecha-
nisms by which these interventions oper-
ate. Do the supplemented organisms
outcompete specific pathogens, do they
simply increase their own numbers, or do
they shift the overall systems-level balance
of many taxa within the community? Do
they reduce the levels of detrimental
metabolites in the host, or do they increase
the levels of beneficial compounds? Do
they change biomolecular activity being
carried out in microbial cells, adjacent
host epithelial or immune cells, or distal
cells through host signaling mechanisms?
Or, as in polygenic genetic disorders, does
a combination of many factors result in
health or disease status as an emergent
phenotype?
The human microbiome has been
referred to as a ‘‘forgotten organ’’ [160],
and the truth of both words is striking.
Our trillions of microbial passengers
account for a proportion of our metabo-
lism and signaling as least as great as that
performed by more integral body parts,
and after a century of molecular biology,
we have only begun to realize their
importance within the last few years. To
close with a success story, the popular
press [161] recently reported on the full
recovery of a patient suffering from
Clostridium difficile-associated diarrhea,
which had led her to lose over 60 pounds
in less than a year. C. difficile is often
refractory to antibiotics, with spores able
to repopulate from very low levels, and the
patient’s normal microbiota had been
decimated by the infection and subsequent
treatment. Finally, she received a simple
fecal transplant from her husband, in
which the host microbiome was replaced
with that of a donor. Within days, not only
had she begun a complete recovery, but a
metagenomic survey of her microbiota
showed that the new community was
almost completely established and had
restored normal taxonomic abundances
[162]. While this is an extreme case,
similar treatments have shown a success
rate of some 90% historically [163], all of
which occurred before modern genomic
techniques allowed us to more closely
examine the microbiota. Imagine perform-
ing any other organ transplant with such a
high rate of success - while blindfolded!
Like so many other discoveries of the
genomic era, the study of the human
microbiome has begun with amazing
achievements, and it will require contin-
ued experimental and bioinformatic efforts
to better understand the biology of these
microbial communities and to see it
translated into clinical practice.
7. Summary
The human microbiome consists of
unicellular microbes - mainly bacterial,
but also archaeal, viral, and eukaryotic -
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bodies and have been linked to a wide
range of phenotypes in health and disease.
High-throughput assays have offered the
first comprehensive culture-free tech-
niques for surveying the members of these
communities and their biomolecular ac-
tivities at the transcript, protein, and
metabolic levels. Most current technolo-
gies rely on DNA sequencing to examine
either individual taxonomic markers in a
microbial community, typically the 16S
ribosomal subunit gene, or the composite
metagenome of the entire community.
Taxonomic analyses lend themselves to
computational techniques rooted in mi-
crobial ecology, including diversity mea-
sures within (alpha) and between (beta)
samples; these can be defined quantita-
tively (based on abundance) or qualitative-
ly (based on presence/absence), and they
may or may not take into account the
phylogenetic relatedness of the taxa being
investigated. Finally, in the absence of
information regarding specific named
species in a community, sequences are
often clustered by similarity into Opera-
tional Taxonomic Units (OTUs) as the
fundamental unit of analysis within a
sample.
In contrast, whole-genome shotgun
analyses begin with sequences sampled
from the entire community metagenome.
These can also be taxonomically binned,
or they can be assembled, partially assem-
bled into ORFeomes, or characterized
directly at the read level. Characterization
typically consists of function assignment
similar to that performed for genes during
annotation of a single organism’s genome;
once genes in the metagenome are de-
fined, they can be mapped or BLASTed to
reference sequence databases or analyzed
intrinsically using e.g. codon frequencies
or HMM profiles. Finally, the frequencies
of enzymes and other gene products so
determined can be assigned to pathways,
allowing inference of the overall metabolic
potential of the community and inference
of diagnostic and potentially explanatory
functional biomarkers. Ongoing studies
are beginning to investigate the ways in
which the microbiota can be directly
engineered using pharmaceuticals, prebio-
tics, probiotics, or diet as a preventative or
treatment for a wide range of disorders.
8. Exercises
Q1. You have a collection of 16S rRNA
gene sequencing data, which consists of an
Illumina run in which the 100 bp V6
hypervariable region has been amplified.
The error rate of Illumina sequencing has
been estimated as 1.3610
23 per base pair
[164], and you have 30 million Illumina
reads. Will binning your reads into OTUs
at 100% or 97% give you a more
interpretable estimation of the number of
OTUs present? Why?
Q2. You have collections of 16S rRNA
gene reads from two environmental sam-
ples, A and B. You examine 50 reads each
from sample A and sample B, which
correspond to four taxa in A and two taxa
in B. You examine 25 more reads from
each library and detect two more taxa in A
and one more in B. In total, two of these
taxa are present in both communities A
and B. Which sample has higher alpha
diversity by counting taxonomic richness?
What is the beta diversity between A and
B using simple overlap of taxa? Using
Bray-Curtis dissimilarity?
Q3. You examine 1,000 more sequenc-
es from samples A and B, detecting 10
additional taxa in A and 25 in B. Which
sample has higher alpha diversity now, as
measured by taxonomic richness? Why is
this different from your previous answer?
What statement can you make about the
ecological evenness of communities A and
B as a result?
Q4. What factors in the microbial
environment might you expect to be
reflected in metabolism, signaling, and
biomolecular function between skin bacte-
ria and oral bacteria? What impact would
you expect this to have on the pathways
carried in these community metagenomes,
or on their alpha diversities?
Q5. It is estimated that 2–5% of the
population has Clostridium difficile in their
intestines. Why is this not usually a
problem?
Q6. Consider the impact upon the
human microbiome of two perturbations:
social contact and brushing your teeth.
What short-term and long-term impact do
you expect on alpha diversity? Beta
diversity?
Q7. Calculate richness, the inverse
Simpson index, and the Shannon index
for each sample described in the table
below. Which has the highest alpha
diversity? Why is the answer different
according to which measurement you use?
Answers to the Exercises can be found
in Text S1.
Supporting Information
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OTU Sample 1 Sample 2 Sample 3
A 20 20 30
B 20 20 30
C 12 0 3 0
D 12 0 0
E 101
Further Reading
It is difficult to recommend comprehensive literature in an area that is changing
so rapidly, but the bioinformatics of microbial community studies are currently
best covered by the reviews in [22,56,165]. Computational tools for metagenomic
analysis include [13,19,63,75,76,77,166]. An overview of microbial ecology from a
phylogenetic perspective is provided in [167,168], and the use of the 16S subunit
as a marker gene is reviewed in [12]. Likewise, experimental and computational
functional metagenomics are discussed in [6,25,169]. The clinical relevance of the
human microbiome is far-ranging and is comprehensively reviewed in [157].
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alpha diversity: within-sample taxonomic diversity
beta diversity: between-sample taxonomic diversity
binning: assignment of sequences to taxonomic units
biofilm: a physically (and often temporally) structured aggregate of microorganisms, often containing multiple taxa, and often
adhered to each other and/or to a defined substrate
chimera: an artificial DNA sequence generated during amplification, consisting of a combination of two (or more) true
underlying sequences
collector’s curve: a plot in which the horizontal axis represents samples (often DNA sequences) and the vertical axis represents
diversity (e.g. number of distinct taxa)
community structure: used most commonly to refer to the taxonomic composition of a microbial community; can also refer to
the spatiotemporal distribution of taxa
diversity: a measure of the taxonomic distribution within a community, either in terms of distinct taxa or in terms of their
evolutionary/phylogenetic distance
FBA: Flux Balance Analysis, a computational method for inferring the metabolic behavior of a system given prior knowledge of
the enzymatic reactions of which it is capable
functional metagenomics: computational or experimental analysis of a microbial community with respect to the biochemical
and other biomolecular activities encoded by its composite genome
gap filling: the process of imputing missing or inaccurate gene abundances in a set of pathways
germ-free: a host animal containing no microorganisms
gnotobiotic: a host animal containing a defined set of microorganisms, either synthetically implanted or transferred from
another host; often used to refer to model organisms with humanized microbiota
holes: missing genes in a set of reference pathways; see gap filling
interpolation: see gap filling
marker: a gene or other DNA sequence that can be (ideally) unambiguously assigned to a particular taxon or function
metagenome: the total genomic DNA of all organisms within a community
metagenomics: the study of uncultured microbial communities, typically relying on high-throughput experimental data and
bioinformatic techniques
metametabolome: the total metabolite pool (and possibly fluxes) of a community
metaproteome: the total proteome of all organisms within a community
metatranscriptome: the total transcribed RNA pool of all organisms within a community
microbiome: the total microbial community and biomolecules within a defined environment
microbiota: the total collection of microbial organisms within a community, typically used in reference to an animal host
microflora: an older term used synonymously with microbiota
ORFeome: the total collection of open reading frames within a metagenome
ortholog: in strict usage, a homologous gene in two species distinguished only by a speciation event; in practice, used to
denote any gene sufficiently homologous as to represent strong evidence for conserved biological function
OTU: Operational Taxonomic Unit, a cluster of organisms similar at the sequence level beyond some threshhold (e.g. 95%) used
in place of species, genus, etc.
phylochip: a microarray containing taxonomic (and sometimes functional) marker sequences
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